Single-port versus multi-port robotic cancer surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two robotic surgery approaches for prostate and kidney cancer—one using a single small incision versus multiple small incisions. The goal is to see if one method works better, is safer, or helps patients recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with prostate cancer (if male) or kidney cancer (male or female)
- Imaging scans (CT or PET) show cancer has not spread to distant parts of your body
- Your doctors believe you are healthy enough for robotic surgery
- You can read, understand, and sign the consent form yourself
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is comparing two different robotic systems (HUGO RAS and Da Vinci) used during surgery for prostate or kidney cancer. If you are scheduled for robot-assisted prostate removal or partial kidney removal, joining this study will help doctors see if one platform works better than the other.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
This trial compares different robotic platforms used to remove kidney tumors while saving healthy kidney tissue. It aims to see which system works best for patients with localized kidney tumors.
This study compares two ways of doing robot‑assisted prostate removal surgery. It aims to see if a newer, less invasive method through a single small cut is as safe and effective as the standard method. If you have early‑stage prostate cancer and are eligible, you could help improve surgical recovery.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.